30 Oct The new Cabinet of Ministers has to deal with competition risks and availability in the market of medicines
As indicated by the the state authority – Competition Council of Latvia, there are systemic problems both in the process of distribution and allocation of medicines, thus affecting its availability to consumers.The research carried out by the Competition Council also leads to a conclusion that market concentration continues to increase in the wholesale of medicines – 83% of the market are occupied by four largest wholesalers, which causes high competition risks.1
Competition Support council as an independent organization dealing with competition issues considers that situation (and so the consequences of vertical integration) has to be changed and its a responsibility of the government. If the legal framework has been created in the past that led to this situation, its time to act more responsible in the interests of society now. There can be several options:
- Competition issues. New players in the Latvian market could be of high importance as well as the public discussion about the sale of specific medicines in the retail market has to be initiated.
Competition Support council hopes that new government that is about to be formed after the recent parliamentary elections will have the political will to put some particular steps in the declaration of the intended activities of the potential Cabinet of Ministers dealing with the problems indicated above.